Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 3661 AL 3675

Targeting voltage-gated calcium channels in neurological and psychiatric diseases

Zamponi GW.

Nat Rev Drug Discov. 2016 Jan;15(1):19-34. doi: 10.1038/nrd.2015.5. Epub 2015 Nov 6.

A review of presented mathematical models in Parkinson's disease: black- and gray-box models

Sarbaz Y, Pourakbari H.

Med Biol Eng Comput. 2016 Jun;54(6):855-68. doi: 10.1007/s11517-015-1401-9. Epub 2015 Nov 7.

Comparative Effect of Power Training and High-Speed Yoga on Motor Function in Older Patients With Parkinson Disease

Ni M, Signorile JF, Mooney K, Balachandran A, Potiaumpai M, Luca C, Moore JG, Kuenze CM, Eltoukhy M, Perry AC.

Arch Phys Med Rehabil. 2016 Mar;97(3):345-354.e15. doi: 10.1016/j.apmr.2015.10.095. Epub 2015 Nov 4.

Development and function of the midbrain dopamine system: what we know and what we need to

Bissonette GB, Roesch MR.

Genes Brain Behav. 2016 Jan;15(1):62-73. doi: 10.1111/gbb.12257. Epub 2015 Nov 8.

Potential role of organochlorine pesticides in the pathogenesis of neurodevelopmental, neurodegenerative, and neurobehavioral disorders: A review

Saeedi Saravi SS, Dehpour AR.

Life Sci. 2016 Jan 15;145:255-64. doi: 10.1016/j.lfs.2015.11.006. Epub 2015 Nov 5.

Neurodegenerative diseases: From available treatments to prospective herbal therapy

Solanki I, Parihar P, Parihar MS.

Neurochem Int. 2016 May;95:100-8. doi: 10.1016/j.neuint.2015.11.001. Epub 2015 Nov 10.

Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories

Tacik P, Sanchez-Contreras M, Rademakers R, Dickson DW, Wszolek ZK.

Neurodegener Dis. 2016;16(1-2):12-21. doi: 10.1159/000440840. Epub 2015 Nov 10.

Pharmacotherapy and generic health-related quality of life in Parkinson's disease

Järvelä JT, Kaasinen V.

Acta Neurol Scand. 2016 Sep;134(3):205-9. doi: 10.1111/ane.12531. Epub 2015 Nov 10.

Lessons from black pepper: piperine and derivatives thereof

Chavarria D, Silva T, Magalhães e Silva D, Remião F, Borges F.

Expert Opin Ther Pat. 2016;26(2):245-64. doi: 10.1517/13543776.2016.1118057. Epub 2015 Dec 5.

Drowning hazard with deep brain stimulation: case report

Bangash OK, Thorburn M, Garcia-Vega J, Walters S, Stell R, Starkstein SE, Lind CR.

J Neurosurg. 2016 May;124(5):1513-6. doi: 10.3171/2015.5.JNS15589. Epub 2015 Nov 13.

Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation

Peña-Altamira E, Prati F, Massenzio F, Virgili M, Contestabile A, Bolognesi ML, Monti B.

Expert Opin Ther Targets. 2016;20(5):627-40. doi: 10.1517/14728222.2016.1121237. Epub 2015 Dec 15.

Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease

Olson KE, Gendelman HE.

Curr Opin Pharmacol. 2016 Feb;26:87-95. doi: 10.1016/j.coph.2015.10.006. Epub 2015 Nov 11.

Laboratory assessments in the course of Parkinson's disease: a clinician's perspective

Müller T, Baas H, Kassubek J, Riederer P, Urban PP, Schrader C, Reichmann H, Woitalla D, Gerlach M.

J Neural Transm (Vienna). 2016 Jan;123(1):65-71. doi: 10.1007/s00702-015-1481-6. Epub 2015 Nov 14.

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells

Goldstein DS, Jinsmaa Y, Sullivan P, Holmes C, Kopin IJ, Sharabi Y.

J Pharmacol Exp Ther. 2016 Feb;356(2):483-92. doi: 10.1124/jpet.115.230201. Epub 2015 Nov 16.

Cost analysis of awake versus asleep deep brain stimulation: a single academic health center experience

Jacob RL, Geddes J, McCartney S, Burchiel KJ.

J Neurosurg. 2016 May;124(5):1517-23. doi: 10.3171/2015.5.JNS15433. Epub 2015 Nov 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias